The store will not work correctly when cookies are disabled.
2-(2,4-dichlorophenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one
ID: ALA1092140
PubChem CID: 5374372
Max Phase: Preclinical
Molecular Formula: C15H8Cl2N2O2
Molecular Weight: 319.15
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1OC(c2ccc(Cl)cc2Cl)=N/C1=C\c1cccnc1
Standard InChI: InChI=1S/C15H8Cl2N2O2/c16-10-3-4-11(12(17)7-10)14-19-13(15(20)21-14)6-9-2-1-5-18-8-9/h1-8H/b13-6-
Standard InChI Key: SRHIORVHIQERHE-MLPAPPSSSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
-3.5916 -9.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6263 -10.4393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9288 -10.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1962 -10.4968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1654 -9.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8636 -9.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8327 -8.4047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1033 -8.0192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4315 -8.5048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7658 -8.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0268 -7.2327 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8518 -7.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3396 -6.5725 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0554 -8.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4615 -8.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2857 -8.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7048 -8.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2937 -7.3127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4708 -7.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0424 -9.4481 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5298 -8.0385 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
9 10 2 0
10 11 1 0
11 12 1 0
12 8 1 0
6 1 1 0
12 13 2 0
1 2 2 0
6 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
7 8 2 0
16 17 2 0
8 9 1 0
17 18 1 0
18 19 2 0
19 14 1 0
10 14 1 0
4 5 1 0
15 20 1 0
2 3 1 0
17 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.15 | Molecular Weight (Monoisotopic): 317.9963 | AlogP: 3.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 51.55 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.68 | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.63 | Np Likeness Score: -1.59 |
References
1. Okamoto M, Takayama K, Shimizu T, Muroya A, Furuya T.. (2010) Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening., 18 (7): [PMID:20206532] [10.1016/j.bmc.2010.02.018] |